CU Startup News
- BioLoomics raises $8.7M to drive directed evolution of target degrading antibodies using human cellsPulse 2.0—91¸£ÀûÉç startup BioLoomics, the company pioneering the directed evolution of target degrading antibodies using human cells, recently announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.
- BizWest—BioLoomics Inc., a 91¸£ÀûÉç spinout, has raised $8.7 million in seed financing. BioLoomics is a preclinical-stage biotechnology company pioneering directed evolution of target-degrading antibodies using human cells.
- Forbes—Prometheus Materials, a 91¸£ÀûÉç spinout, has a solution for replacing one of the biggest contributors of greenhouse gasses, financial backing from Microsoft and an aggressive plan to scale up quickly.
- U.S. Department of Energy—Latimer Controls, a 91¸£ÀûÉç spinout, is developing intelligent control software that enables utility-scale photovoltaics (PV) to provide power reliably and on demand. This will replace grid reliance on fossil fuels, drive higher profitability for PV operators and generate revenue increases for solar asset owners with low capital cost.
- Innosphere Ventures—Aspero Medical, a 91¸£ÀûÉç spinout and medical device startup focused on the design and development of innovative technology to improve gastrointestinal (GI) endoscopy procedures, has received clearance from the Food and Drug Administration (FDA) to market and sell the Ancora-SB small bowel balloon overtube.
- Duality Accelerator—The first stage in creating a scalable quantum network requires the consistent generation of photons, the smallest possible quantum of light. Where do these photons come from? If you ask Poolad Imany, founder and CEO of 91¸£ÀûÉç startup Icarus Quantum, he’d say from devices developed by his company.
- Denver Post—Solid Power, a 91¸£ÀûÉç spinout, is producing the material for solid state battery cells in a new 75,000-square-foot factory in Thornton and is looking at expanding operations globally in the next year or so.
- Business Wire—Cascade Biocatalysts (formerly Rigid Biotech), a 91¸£ÀûÉç startup and biomanufacturing company catalyzing green chemistry, raised an oversubscribed $2.6 million pre-seed. Cascade aims to use the raised funds to scale its impact from the lab bench to pilot scale and support its initial wave of customers.
- The Embark Deep Tech Startup Creator at Venture Partners at 91¸£ÀûÉç has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from 91¸£ÀûÉç's research labs to bring them to market and unleash the full impact of 91¸£ÀûÉç's research into the world.
- Denver Post—Meati Foods, a 91¸£ÀûÉç-based producer of plant-based meat alternatives and 91¸£ÀûÉç spinout, is expanding its commercial reach by selling to Whole Foods Markets across the country.